One resident in Hingham thwarted a scam seeking $3,000. Scammers are impersonating planning and zoning officials, demanding fake fees from residents.

The FDA has accepted the New Drug Application for Priority Review for oveporexton in the treatment of narcolepsy type 1.

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the most oversold NASDAQ stocks to invest in. On February 2, H.C. Wainwright ...

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu ...

The same social engineering techniques used to extract money and information from victims increasingly feed application fraud and identity misuse.

It’s rare that FDA refuses to file an application, particularly for a new vaccine, which requires companies and FDA staff to engage in months or years of discussions.

Orion Security has secured $32 million in Series A funding led by Norwest Venture Partners to replace policy-driven data loss ...

Diabetic foot ulcer (DFU), a severe chronic complication of diabetes mellitus, poses a major public health threat due to its high rates of disability, recurrence, and all-cause mortality. The ...

FDA assigned PDUFA target action date of July 7, 2026. If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN. Atacicept received FDA Breakthrough Therapy ...

Target shoppers reported issues with the company's website and app Friday amid the final days of the major holiday shopping rush. Users took to social media to question issues they began experiencing ...